European Commission allows Glycom A/S to place lacto-N-tetraose (‘LNT’), obtained by microbial fermentation with a genetically modified strain of Escherichia coli, strain K12 DH1, on the Union market as a novel food. CLICK HERE Tags: HMO, LNT, novel food Read more articles Previous PostFermented Food Consumption Associated with Changes in the Gut Microbiome Next PostThe Global Prebiotic Association Welcomes FrieslandCampina Ingredients as a New Member You Might Also Like Tailored Impact of Dietary Fibers on Gut Microbiota in Lean and Obese Communities December 20, 2024 Synbiotic Approach to Immunity and Metabolism in the Elderly December 2, 2020 Prebiotics talk to cells when exhibiting gut benefits May 15, 2020